Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA should listen to patients, not just clinical trial data, on rare disease therapies
FDA should listen to patients, not just clinical trial data, on rare disease therapies
FDA should listen to patients, not just clinical trial data, on rare disease therapies
Submitted by
admin
on May 10, 2016 - 9:42am
Source:
Stat
News Tags:
Marco Rubio
FDA
orphan diseasese
Rare Diseases
patients
Headline:
FDA should listen to patients, not just clinical trial data, on rare disease therapies
Do Not Allow Advertisers to Use My Personal information
